Marion McCourt

Track

Insider profile

Currently holds a position at Regeneron Pharmaceuticals, Inc.

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 39% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Commercial Regeneron Pharmaceuticals, Inc. Feb. 12, 2018 -
Director SCYNEXIS Inc Jan. 25, 2017 - Sept. 18, 2018
Director CytomX Therapeutics, Inc. March 29, 2017 - June 13, 2018
President, Chief Operating Officer Axovant Gene Therapies Ltd April 1, 2017 - Feb. 13, 2018
Chief Operating Officer Medivation Inc Feb. 1, 2016 - Sept. 28, 2016
Marion McCourt's trades of Regeneron Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-30 2026-10-30
PrS Proposed sale
81,290
265.97
US$4,998,020 		81,290 265.97 US$4,998,020
2026-09-03 2026-09-03
PlS Planned sale
57,164 -44.8%
380.22
US$683,171 		57,164 -44.8% 380.22 US$683,171
2026-09-03 2026-09-03
PrS Proposed sale
63,287
115.10
US$1,130,308 		63,287 115.10 US$1,130,308
2026-09-03 2026-09-02
PlS Planned sale
1,215 -8.5%
850.00
US$1,032,750 		1,215 -8.5% 850.00 US$1,032,750
2026-09-02 2026-09-02
PrS Proposed sale
1,215
850.00
US$1,032,750 		1,215 850.00 US$1,032,750
2024-11-05 2024-11-01
PlS Planned sale
1,000 -7.2%
844.61
US$844,610 		1,000 -7.2% 844.61 US$844,610
2024-11-01 2024-11-01
PrS Proposed sale
1,000
844.61
US$844,610 		1,000 844.61 US$844,610
2024-10-03 2024-10-01
PlS Planned sale
1,000 -7.2%
1,054.06
US$1,054,060 		1,000 -7.2% 1,054.06 US$1,054,060
2024-10-01 2024-10-01
PrS Proposed sale
1,000
1,054.06
US$1,054,060 		1,000 1,054.06 US$1,054,060
2024-09-05 2024-09-03
PlS Planned sale
1,000 -7.2%
1,178.73
US$1,178,730 		1,000 -7.2% 1,178.73 US$1,178,730
2024-09-03 2024-09-03
PrS Proposed sale
1,000
1,178.73
US$1,178,730 		1,000 1,178.73 US$1,178,730
2024-08-05 2024-08-01
PlS Planned sale
1,137 -8.1%
1,060.86
US$1,206,198 		1,137 -8.1% 1,060.86 US$1,206,198
2024-08-01 2024-08-01
PrS Proposed sale
1,137
1,060.86
US$1,206,198 		1,137 1,060.86 US$1,206,198
2024-07-02 2024-07-01
PlS Planned sale
1,137 -8.1%
1,047.11
US$1,190,564 		1,137 -8.1% 1,047.11 US$1,190,564
2024-07-01 2024-07-01
PrS Proposed sale
1,137
1,047.11
US$1,190,564 		1,137 1,047.11 US$1,190,564
2024-06-05 2024-06-03
PlS Planned sale
1,138 -8.1%
980.16
US$1,115,422 		1,138 -8.1% 980.16 US$1,115,422
2024-06-03 2024-06-03
PrS Proposed sale
1,138
980.16
US$1,115,422 		1,138 980.16 US$1,115,422
2024-05-03 2024-05-01
PlS Planned sale
250 -1.9%
889.41
US$222,352 		250 -1.9% 889.41 US$222,352
2024-05-03 2024-05-01
PlS Planned sale
250 -1.9%
889.41
US$222,352 		250 -1.9% 889.41 US$222,352
2024-05-01 2024-05-01
PrS Proposed sale
250
889.41
US$222,352 		250 889.41 US$222,352
2024-04-03 2024-04-01
PlS Planned sale
250 -1.9%
964.73
US$241,182 		250 -1.9% 964.73 US$241,182
2024-04-01 2024-04-01
PrS Proposed sale
250
964.73
US$241,182 		250 964.73 US$241,182
2024-03-05 2024-03-01
PlS Planned sale
358 -2.6%
967.50
US$346,365 		358 -2.6% 967.50 US$346,365
2024-03-01 2024-03-01
PrS Proposed sale
358
967.50
US$346,365 		358 967.50 US$346,365
2024-02-06 2024-02-05
S Sale
1,000 -6.8%
934.71
US$934,710 		1,000 -6.8% 934.71 US$934,710
2024-02-05 2024-02-05
PrS Proposed sale
1,000
934.71
US$934,710 		1,000 934.71 US$934,710
2024-02-02 2024-02-01
PlS Planned sale
273 -1.8%
945.61
US$258,152 		273 -1.8% 945.61 US$258,152
2024-02-01 2024-02-01
PrS Proposed sale
273
945.61
US$258,152 		273 945.61 US$258,152
2024-01-04 2024-01-02
PlS Planned sale
274 -1.8%
873.91
US$239,451 		274 -1.8% 873.91 US$239,451
2024-01-02 2024-01-02
PrS Proposed sale
274
873.91
US$239,451 		274 873.91 US$239,451
2023-12-12 2023-12-11
PlS Planned sale
270 -1.3%
838.44
US$226,379 		270 -1.3% 838.44 US$226,379
2023-12-11 2023-12-11
PrS Proposed sale
270
838.44
US$226,379 		270 838.44 US$226,379
2023-11-02 2023-11-01
PlS Planned sale
1,000 -4.8%
783.91
US$783,910 		1,000 -4.8% 783.91 US$783,910
2023-11-01 2023-11-01
PrS Proposed sale
1,000
783.91
US$783,910 		1,000 783.91 US$783,910
2023-10-03 2023-10-02
PlS Planned sale
1,038 -5.0%
827.00
US$858,426 		1,038 -5.0% 827.00 US$858,426
2023-10-02 2023-10-02
PrS Proposed sale
1,038
827.00
US$858,426 		1,038 827.00 US$858,426
2023-09-06 2023-09-01
PlS Planned sale
250 -1.2%
834.55
US$208,638 		250 -1.2% 834.55 US$208,638
2023-09-01 2023-09-01
PrS Proposed sale
250
834.55
US$208,638 		250 834.55 US$208,638
2023-08-03 2023-08-01
PlS Planned sale
250 -1.2%
744.66
US$186,165 		250 -1.2% 744.66 US$186,165
2023-08-01 2023-08-01
PrS Proposed sale
250
744.66
US$186,165 		250 744.66 US$186,165
2023-07-06 2023-07-03
PlS Planned sale
250 -1.2%
710.09
US$177,522 		250 -1.2% 710.09 US$177,522
2023-07-03 2023-07-03
PrS Proposed sale
250
710.09
US$177,522 		250 710.09 US$177,522
2023-06-02 2023-06-01
PlS Planned sale
250 -1.2%
736.00
US$184,000 		250 -1.2% 736.00 US$184,000
2023-06-01 2023-06-01
PrS Proposed sale
250
736.00
US$184,000 		250 736.00 US$184,000
2023-04-05 2023-04-03
PlS Planned sale
1,100 -5.0%
818.80
US$900,680 		1,100 -5.0% 818.80 US$900,680